Renal clearance
The removal of a peptide from the blood by the kidneys. Smaller peptides (below ~60 kDa) are filtered by the glomerulus. PEGylation increases molecular size to reduce renal clearance and extend half-life.
Frequently Asked Questions
What is Renal clearance?
Why is Renal clearance important in peptide research?
Related Terms
The volume of blood from which a peptide is completely removed per unit time, expressed in mL/min or L/hr. Clearance determines dosing frequency along with half-life.
PEGylationThe covalent attachment of polyethylene glycol (PEG) chains to a peptide. PEGylation increases molecular size, reduces renal clearance, and extends half-life. Used in semaglutide and other long-acting peptide drugs.
Half-lifeThe time required for the concentration of a peptide in the body to decrease by half. Determines dosing frequency — short half-life peptides (minutes) need daily dosing, while long half-life peptides (days) can be dosed weekly.
Hepatic metabolismThe breakdown of peptides by liver enzymes. Most peptides are degraded by proteases rather than CYP450 enzymes, which means fewer drug-drug interactions compared to small-molecule drugs.